STARTUP LEGAL18 Sept 2026
‘Adherence to regulations’: Nestle India responds to FSSAI action over infant food products – NAN Excella, Lactogen Pro | Company Business News
India's food regulator, FSSAI, has started legal action against Nestle India over its infant nutrition products, NAN Excella Pro and Lactogen Pro. FSSAI says label claims about 5HMOs and Whey Protein break infant food rules, and three adjudication cases are filed. Nestle denies this, saying its labels were approved and are fully compliant. If you sell or market infant nutrition products, check every label claim now.
Key Statutory Highlights
- FSSAI has filed three separate adjudication cases against Nestle India covering NAN Excella Pro Stage 1, Lactogen Pro 1 and a follow-up formula.
- FSSAI flagged claims about "5HMOs" and "Whey Protein", saying they contravene Regulation 4(2) of the Food Safety and Standards (Foods for Infant Nutrition) Regulations, 2020 and Section 3 of the Infant Milk Substitutes Act, 1992.
- A follow-up formula sample made by Nestle India was found sub-standard for Biotin content, and the referral laboratory also found it non-conforming, FSSAI said.
Actionable Advice for Taxpayers / Founders:If your business makes, sells or advertises infant nutrition products, review your label claims and promotional material against FSSAI's infant food rules and take professional advice before publishing them.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: